Estimates and trends of hospital and outpatient pharmaceutical expenditure in European countries
| Country; reference years | Percentage (%) of hospital PE to total PE (reference year) | Change in hospital PE, % | CAGR of hospital PE, % | Change in outpatient PE, % | Change in total PE, % |
| Belgium; 2013-20199 | 49.3 (2019) | 88.2 | 9.5 | 1.1 | 31.1 |
| Denmark; 2012-202010 | 47.5 (2020) | 51.0 | 4.9 | 6.0 | 23.5 |
| Finland; 2012-201811 | 22.2 (2018) | 56.9 | 6.7 | 12.6 | 19.3 |
| France; 2010-201412 | 20.0 (2014) | 6.8 | 1.6 | −3.0 | −1.5 |
| Germany; 2010-201412 | 21.4 (2014) | −2.3 | −1.1 | 2.3 | 1.0 |
| Greece; 2012-201913 | 23.5 (2019) | −21.6 | −3.4 | −32.5 | −30.2 |
| Ireland; 2012-201614 | 21.2 (2016) | 38.5 | 8.5 | −2.8 | 3.8 |
| Italy; 2011-201915 | 38.1 (2019) | 88.1 | 8.2 | −4.3 | 17.8 |
| The Netherlands; 2010-201412 | 28.4 (2014) | 41.7 | 9.2 | −5.6 | 1.9 |
| Poland; 2010-201412 | 33.5 (2014) | 31.0 | 7.0 | 0.7 | 5.7 |
| Spain; 2014-201616 | 38.3 (2016) | 18.3 | 8.8 | 5.9 | 10.3 |
| Sweden; 2010-201617 | 23.5 (2016) | 16.2 | 2.5 | 8.9 | 10.5 |
| UK; 2011-202018 | 55.9 (2020) | 179.9 | 12.1 | 4.4 | 60.7 |
| Average | 32.5 | 45.6 | 5.7 | −0.5 | 11.8 |
CAGR, compound annual growth rate; PE, pharmaceutical expenditure.